Lepu launches AI-powered Neo ECG tablet

Recently, Shenzhen Carewell Electronics Co., Ltd., a subsidiary of Lepu Medical (300003. SZ), launched its new ECG tablets--Neo ECG T180 and Neo ECG S120. Supporting connection with AI-ECG Platform, Neo ECG tablet allows the hospitals and medical centers to achieve intelligence diagnosis. This marks Lepu's solid step towards AI-powered solutions.  

What Is An AI-ECG Platform?  

Independently developed by Lepu Medical, AI-ECG Platform is an assisted analysis and diagnosis systemof artificial intelligence (AI) electrocardiogram (ECG) . It provides an intelligent in-hospital solution to assist clinical decision-making.  

Highlights of AI ECG Platform

• The analysis results turn out to be highly accurate. Tested by 1,000,000 independent MIT test data, the average accuracy of AI-ECG platform reaches 95.2%.  

• Its high-speed feature makes it a time-saver. The AI-ECG Platform takes merely 1 second to rest ECG analysis automatically, which can reduce the overall time of clinical ECG analysis.  

• It enables comprehensive diagnosis. ThisAI ECG platform supports 16 types of cardiac malfunction classification and 104 types of ECG diagnostic classification.  

Main Features of Neo ECG Tablets

• 7'' / 10.1'' high resolution color touch screen, easy to operate  

• Base with build-in thermal printer and support external laser printer

• Support connection with AI-ECG PLATFORM in achieving intelligence diagnosis.  

For more information on Lepu Medical Neo ECG Tablet, please visit: https://en.lepumedical.com/products/neo-ecg/